Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of immunological reagents. The company develops monoclonal antibodies for the treatment of cancer, brain damage and tumors.
You’re viewing a free company profile from the PitchBook Platform. To explore CanAg Diagnostics’s full profile, request a free trial.
1 Former Executive
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.